expert reaction to systematic review and meta-analysis of psilocybin for depression
A study published in the BMJ looks at psilocybin for treating depression symptoms. Prof David Nutt, The Edmond J Safra … read more
A study published in the BMJ looks at psilocybin for treating depression symptoms. Prof David Nutt, The Edmond J Safra … read more
Scientists react to Elon Musk claiming that he used ketamine for depression. Dr Rupert McShane, Consultant Psychiatrist at Oxford … read more
Scientists react to media reports about pregabalin for anxiety. Prof Glyn Lewis, Professor of Psychiatric Epidemiology, University College London … read more
A study published in The BMJ looks at the effect of exercise on depression. Prof Mark Hamer, Professor of Sport and … read more
It was reported that Matthew Perry’s death was partly caused by acute effects of ketamine. Matthew Perry had previously received … read more
A study published in JAMA Network Open looks at ultra processed food and the risk of depression. Priya Tew, Registered dietitian … read more
A study published in Diabetes Care looks at the relationship between type 2 diabetes and depression. Dr Paul Keedwell, … read more
A study published in Nature Neuroscience suggests that psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Dr … read more
Results from a trial looking at ketamine versus ECT for nonpsychotic treatment-resistant major depression have been published in the NEJM. … read more
The National Institute for Health and Care Excellence (NICE) have published a new draft guidance conditionally recommending eight digital enabled therapies … read more
Millions of people around the world are prescribed antidepressants to treat chronic pain. In many countries, including the UK, regulators … read more
A meta-analysis published by Cochrane looks at the use of antidepressants for pain management in adults with chronic pain. This … read more
A systematic review published in JAMA Psychiatry looks at the use of ketamine vs electroconvulsive therapy (ECT) for major depressive … read more
A study published in PNAS suggests that antidepressants can induce mutation and enhance persistence towards multiple antibiotics. The following … read more
Results from the Phase IIb clinical trial of single-dose psilocybin for treatment-resistant depression have been published in The New England … read more
A study published in JAMA Internal Medicine looks at antidepressant use during pregnancy and risk of neurodevelopmental disorders in children. … read more
A review paper published in Molecular Psychiatry looks at the ‘serotonin theory of depression’. Prof Gitte Moos Knudsen, Professor … read more
A study published in the European Journal of Population looks at the well-being of adolescents conceived through medically assisted reproduction. … read more
A study published in JAMA Psychiatry looks at neuropsychiatric consequences of severe COVID-19 and other severe acute respiratory infections. … read more
A study published in PLOS ONE looks at antidepressants and health-related quality of life (HRQoL) for patients with depression. … read more